Off-label Use of Itolizumab in Patients with COVID-19 ARDS: Our Clinical Experience in a Dedicated COVID Center

Severe acute respiratory syndrome coronavirus 2 has affected millions of people worldwide. This pandemic requires newer medical management strategies to control the morbidity and mortality associated with the disease. Several approaches, including global targeting of inflammation or neutralizing a s...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumari, Poonam, Kumar, Amarjeet, Sinha, Chandni, Kumar, Ajeet, Singh, Prabhat K, Arun, SK
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138631/
https://www.ncbi.nlm.nih.gov/pubmed/34045817
http://dx.doi.org/10.5005/jp-journals-10071-23787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138631/
https://www.ncbi.nlm.nih.gov/pubmed/34045817
http://dx.doi.org/10.5005/jp-journals-10071-23787

Ejemplares similares